CytoDyn Inc. approved a management reorganization pursuant to which Nitya G. Ray, Ph.D., will continue in his role as Chief Technology Officer, but will no longer serve as Chief Operating Officer. Also, Christopher P. Recknor, M.D., will serve as Senior Director of Research and Development, but will no longer be an executive officer of the Company as defined in the rules of the Securities and Exchange Commission.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1488 USD | -2.49% | -6.53% | -24.36% |
05-30 | Transcript : CytoDyn Inc. - Special Call | |
05-03 | CytoDyn Inc. announced that it has received $8.942 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-24.36% | 161M | |
+18.98% | 125B | |
+14.05% | 108B | |
-4.06% | 24.57B | |
+3.23% | 22.82B | |
-10.44% | 18.19B | |
-41.74% | 16.54B | |
-12.35% | 16.5B | |
+2.64% | 13.39B | |
+27.27% | 11.1B |
- Stock Market
- Equities
- CYDY Stock
- News CytoDyn Inc.
- CytoDyn Inc. Announces Executive Changes